1
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects
Condition(s):Lupus Erythematosus, CutaneousLast Updated:May 23, 2019Completed
Lupus Erythematosus, Cutaneous: 91 Clinical Trials
Hide Studies Not Open or Pending
2
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Condition(s):Systemic Lupus Erythematosus; Active Cutaneous Lupus ErythematosusLast Updated:October 24, 2019Active, not recruiting
3
European Society of Cutaneous Lupus Erythematosus (EUSCLE)
Condition(s):Lupus Erythematosus, Cutaneous; Lupus Erythematosus, SystemicLast Updated:February 7, 2017Unknown status
4
Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)
Condition(s):Cutaneous Lupus ErythematosusLast Updated:October 29, 2019Active, not recruiting
5
Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser
Condition(s):Cutaneous Lupus ErythematosusLast Updated:June 24, 2010Completed
6
Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus
Condition(s):Subacute Cutaneous Lupus ErythematosusLast Updated:March 20, 2017Completed
7
Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus
Condition(s):Cutaneous Lupus ErythematosusLast Updated:April 15, 2013Completed
8
Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus
Condition(s):Lupus Erythematosus, CutaneousLast Updated:February 27, 2014Completed
9
A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus
Condition(s):Lupus Erythematosus, Cutaneous; Lupus Erythematosus, SystemicLast Updated:October 5, 2012Completed
10
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
Condition(s):Cutaneous Lupus ErythematosusLast Updated:January 27, 2014Terminated
11
Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus
Condition(s):Lupus Erythematosus, CutaneousLast Updated:May 30, 2016Terminated
12
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
Condition(s):Cutaneous Lupus ErythematosusLast Updated:July 14, 2015Completed
13
Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion
Condition(s):Cutaneous Lupus Erythematosus-Systemic Lupus ErythematosusLast Updated:May 12, 2014Completed
14
Cutaneous Lupus Erythematosus and Elidel
Condition(s):Lupus Erythematosus, Cutaneous; Lupus Erythematosus, DiscoidLast Updated:June 27, 2018Withdrawn
15
Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)
Condition(s):Cutaneous Lupus ErythematosusLast Updated:September 7, 2007Completed
16
Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus
Condition(s):Cutaneous Lupus ErythematosusLast Updated:April 10, 2019Recruiting
17
To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus
Condition(s):Cutaneous Lupus ErythematosusLast Updated:November 7, 2019Completed
18
Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)
Condition(s):Cutaneous Lupus Erythematosus (CLE)Last Updated:October 24, 2019Completed
19
Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus
Condition(s):Cutaneous Lupus Erythematosus; Systemic Lupus Erythematosus RashLast Updated:September 22, 2017Unknown status
20
A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren’s Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis
Condition(s):Systemic Lupus Erythematosus; Cutaneous Lupus Erythematosus; Sjogren’s Syndrome; Systemic Sclerosis; Polymyositis; DermatomyositisLast Updated:November 25, 2019Recruiting
21
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Condition(s):Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Lupus Erythematosus, Discoid; HealthyLast Updated:December 15, 2016Completed
22
Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE)
Condition(s):Cutaneous Lupus ErythematosusLast Updated:March 8, 2016Completed
23
Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus
Condition(s):Cutaneous Lupus ErythematosusLast Updated:November 18, 2013Terminated
24
A Non-drug Study Profiling Cutaneous Lupus
Condition(s):Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Lupus Erythematosus, DiscoidLast Updated:September 11, 2014Completed
25
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Condition(s):Cutaneous Lupus; LupusLast Updated:January 9, 2014Terminated
26
Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)
Condition(s):Cutaneous Lupus ErythematosusLast Updated:December 11, 2013Completed
27
Sunscreen RV 2457C in Photoinduced CLE
Condition(s):Cutaneous Lupus Erythematosus; Skin Lesion; Experimental Photoinduction; Protective SunscreenLast Updated:May 7, 2007Completed
28
Pilot Tape Harvesting Study
Condition(s):Atopic Dermatitis; Healthy; Discoid Lupus Erythematosus; Subacute Cutaneous Lupus ErythematosusLast Updated:September 27, 2016Completed
29
Low-dose UVA1 Radiation in Cutaneous Lupus Patients
Condition(s):Cutaneous Lupus ErythematosusLast Updated:November 15, 2018Recruiting
30
Autologous Polyclonal Tregs for Lupus
Condition(s):Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Lupus Erythematosus, SystemicLast Updated:October 22, 2019Terminated
31
Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus
Condition(s):Lupus Erythematosus, Discoid; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Chronic CutaneousLast Updated:February 26, 2019Completed
32
Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients
Condition(s):Discoid Lupus ErythematosusLast Updated:December 10, 2012Completed
33
Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid
Condition(s):Pemphigoid, Bullous; Pemphigus; Lupus Erythematosus, CutaneousLast Updated:May 4, 2018Terminated
34
Efficacy of 595 nm Pulsed-dye Laser in Treatment of Discoid Lupus Erythematosus
Condition(s):Lupus Erythematosus, DiscoidLast Updated:June 5, 2017Unknown status
35
Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)
Condition(s):Discoid Lupus Erythematosus; Systemic Lupus ErythematosusLast Updated:May 31, 2019Recruiting
36
Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus
Condition(s):Cutaneous Lupus; Discoid Lupus; Lupus; Systemic Lupus ErythematosusLast Updated:September 12, 2014Terminated
37
A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)
Condition(s):Systemic Lupus ErythematosusLast Updated:July 19, 2019Active, not recruiting
38
Cutaneous Lupus Registry
Condition(s):Lupus ErythematosusLast Updated:November 15, 2018Recruiting
39
Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus
Condition(s):Cutaneous Lupus; Systemic Lupus ErythematosusLast Updated:July 22, 2019Recruiting
40
Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids Alone
Condition(s):Cutaneous LupusLast Updated:April 15, 2019Recruiting
41
A Study to Assess the Safety and Efficacy of Secukinumab in Alleviating Symptoms of Discoid Lupus Erythematosus
Condition(s):Discoid Lupus ErythematosusLast Updated:March 6, 2019Not yet recruiting
42
Phase Ib Study of SC Milatuzumab in SLE
Condition(s):Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Lupus NephritisLast Updated:October 1, 2015Unknown status
43
TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment
Condition(s):Lupus Erythematosus, SystemicLast Updated:May 21, 2018Terminated
44
Cutaneous Lupus Medication Experience Study
Condition(s):Cutaneous LupusLast Updated:November 11, 2019Active, not recruiting
45
A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus
Condition(s):Discoid LupusLast Updated:November 14, 2019Terminated
46
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
Condition(s):Lupus Erythematosus, Discoid; Lupus Erythematosus, SystemicLast Updated:June 15, 2016Completed
47
A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies
Condition(s):Lupus Erythematosus, DiscoidLast Updated:May 16, 2013Completed
48
Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva
Condition(s):Discoid Lupus Erthematosus of the Scalp.Last Updated:May 22, 2007Terminated
49
The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus
Condition(s):Discoid Lupus Erythematosus (DLE)Last Updated:May 25, 2010Unknown status
50
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
Condition(s):LupusLast Updated:October 3, 2019Completed
51
Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.
Condition(s):Discoid Lupus ErythematosusLast Updated:November 8, 2019Recruiting
52
Duke Lupus Registry
Condition(s):Systemic Lupus Erythematosus; Cutaneous LupusLast Updated:October 21, 2019Recruiting
53
Photoprovocation Testing in Subjects With Cutaneous Lupus
Condition(s):Lupus Erythematosus; Photosensitivity ConditionsLast Updated:April 10, 2019Recruiting
54
Systemic Lupus Erythematosus Exercise Program
Condition(s):Systemic Lupus ErythematosusLast Updated:May 7, 2019Recruiting
55
The Human Microbiome in Immune-Mediated Diseases
Condition(s):AutoimmuneLast Updated:July 9, 2019Active, not recruiting
56
A Study of NKTR-358 in Participants With Systemic Lupus Erythematosis (SLE)
Condition(s):Systemic Lupus ErythematosusLast Updated:October 7, 2019Completed
57
Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus
Condition(s):Discoid Lupus ErythematosusLast Updated:February 6, 2008Completed
58
Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions
Condition(s):Discoid Lupus ErythematosusLast Updated:February 28, 2008Completed
59
Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)
Condition(s):Discoid Lupus ErythematosusLast Updated:February 28, 2008Completed
60
A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus
Condition(s):Discoid Lupus ErythematosusLast Updated:March 3, 2008Completed
61
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Condition(s):Systemic Lupus ErythematosusLast Updated:March 23, 2018Completed
62
A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus
Condition(s):Lupus Erythematosus, SystemicLast Updated:February 12, 2019Completed
63
Safety and Efficacy of AMG 592 in Subjects With Active Systemic Lupus Erythematosus
Condition(s):Systemic Lupus ErythematosusLast Updated:October 22, 2019Recruiting
64
A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus
Condition(s):Lupus Erythematosus, SystemicLast Updated:November 26, 2019Not yet recruiting
65
A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus
Condition(s):Lupus Erythematosus, SystemicLast Updated:November 26, 2019Recruiting
66
Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care
Condition(s):Systemic Lupus ErythematosusLast Updated:January 28, 2019Recruiting
67
A Study to Investigate the Safety and Efficacy of ABBV-105 and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Condition(s):Systemic Lupus Erythematosus (SLE)Last Updated:December 5, 2019Recruiting
68
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
Condition(s):Systemic Lupus Erythematosus (SLE)Last Updated:November 23, 2016Unknown status
69
Safety and Efficacy of SM934 Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Condition(s):Systemic Lupus ErythematosusLast Updated:September 3, 2019Recruiting
70
An Investigational Study to Evaluate BMS-986165 in Patients With Systemic Lupus Erythematosus
Condition(s):Systemic Lupus ErythematosusLast Updated:October 21, 2019Recruiting
71
Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)
Condition(s):Systemic Lupus Erythematosus (SLE)Last Updated:November 26, 2019Not yet recruiting
72
A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Condition(s):Systemic Lupus ErythematosusLast Updated:December 5, 2019Recruiting
73
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Condition(s):Systemic Lupus ErythematosusLast Updated:November 7, 2019Active, not recruiting
74
Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Condition(s):Active Systemic Lupus ErythematosusLast Updated:September 19, 2019Completed
75
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)
Condition(s):Systemic Lupus ErythematosusLast Updated:December 2, 2019Recruiting
76
A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus
Condition(s):Systemic Lupus ErythematosusLast Updated:December 2, 2019Recruiting
77
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus
Condition(s):Systemic Lupus ErythematosusLast Updated:December 2, 2019Recruiting
78
Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases
Condition(s):Systemic Lupus Erythematosus (SLE); Juvenile SLE; Cutaneous LupusLast Updated:April 18, 2018Recruiting
79
Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Condition(s):Active Systemic Lupus ErythematosusLast Updated:November 18, 2019Completed
80
Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Children
Condition(s):InfluenzaLast Updated:September 25, 2018Completed
81
Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia
Condition(s):Central Centrifugal Scarring Alopecia; Lichen Planopilaris; Discoid Lupus ErythematosusLast Updated:July 3, 2018Completed
82
Prediction of Relapse Risk in Stable Systemic Lupus Erythematosus
Condition(s):Systemic Lupus ErythematosusLast Updated:July 15, 2019Recruiting
83
Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis
Condition(s):Systemic SclerosisLast Updated:March 15, 2017Completed
84
Study of Anti-Malarials in Incomplete Lupus Erythematosus
Condition(s):Systemic Lupus ErythematosusLast Updated:June 17, 2019Recruiting
85
Neutrophil Extracellular Traps in Systemic Sclerosis
Condition(s):Systemic Lupus Erythematosus; Systemic SclerosisLast Updated:December 14, 2017Unknown status
86
Effects of Treatment of Chronic Stress in Patients With Lupus
Condition(s):Systemic Lupus ErythematosusLast Updated:June 6, 2007Completed
87
Cervarix Long-term Safety Surveillance
Condition(s):Infections, PapillomavirusLast Updated:April 2, 2015Completed
88
Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain
Condition(s):Lupus Erythematosus, Systemic; Musculoskeletal PainLast Updated:October 8, 2019Enrolling by invitation
89
Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases
Condition(s):Systemic Lupus Erythematosus; Systemic SclerosisLast Updated:June 21, 2016Terminated
90
Calcipotriol and Polymorphic Light Eruption
Condition(s):Polymorphic Light EruptionLast Updated:October 2, 2009Completed
91
A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus
Condition(s):Lupus Erythematosus, SystemicLast Updated:August 27, 2019Active, not recruiting